Vyant Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vyant Bio generated cash of -$13,681,000, which is more than the previous year. Cash used in financing activities reached the amount of -$149,000 last year. Net change in cash is therefore -$10,567,000.
Cash Flow
| 2013 | -8.07M | -1.39M | 58.11M |
|---|---|---|---|
| 2014 | -12.33M | -11.37M | -195.10K |
| 2015 | -13.59M | -2.64M | 10.14M |
| 2016 | -17.85M | -609K | 8.50M |
| 2017 | -13.56M | -2.75M | 16.33M |
| 2018 | -12.55M | 1.08M | 2.14M |
| 2019 | -8.66M | 9.09M | 3.30M |
| 2020 | -5.81M | -43K | 6.33M |
| 2021 | -16.99M | 29.61M | 7.19M |
| 2022 | -13.68M | 3.26M | -149K |
VYNT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.60M | 792K | 315K | 511K | 9.89M | 9.50M | 19.45M | 25.55M | 49.45M | 819.90K |
Operating activities | ||||||||||
Net income | -22.69M | -40.85M | -8.65M | -6.70M | -20.37M | -20.88M | -15.80M | -20.18M | -16.64M | -12.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 843K | 1.05M | 1.11M | 757K | 2.11M | 2.16M | 2.37M | 1.66M | 838.59K | 326.47K |
Stock-based compensation expense | 1.18M | 1.00M | 372K | 0 | 0 | 0 | 0 | 0 | 0 | 646.98K |
| Deferred income tax benefit | 1.18M | 1.00M | 372K | 0 | 0 | 0 | 0 | 0 | 0 | 646.98K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 111K | -77K | -246K | 81K | 1.04M | -3.58M | -5.85M | -1.66M | -1.65M | -716.49K |
Inventories | 422K | -60K | -43K | 19.20M | -8.37M | -7.25M | -12.83M | -28.85M | -42.28M | 11.05M |
Accounts payable | -85K | -1.14M | 878K | -1.34M | 3.76M | -1.53M | 355K | 3.11M | 673.68K | -731.47K |
Cash generated by operating activities | -13.68M | -16.99M | -5.81M | -8.66M | -12.55M | -13.56M | -17.85M | -13.59M | -12.33M | -8.07M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -200K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -617K | -535K | -60K | -28K | -680K | -1.41M | -609K | -1.14M | -1.50M | -349.43K |
Acquisitions Net | 0 | 30.16M | 0 | 0 | 0 | -1M | 0 | 0 | -3M | 0 |
Cash generated by investing activities | 3.26M | 29.61M | -43K | 9.09M | 1.08M | -2.75M | -609K | -2.64M | -11.37M | -1.39M |
Financing activities | ||||||||||
Common Stock Issued | -188K | 41K | 1.34M | 5.41M | 0 | 9.55M | 9.96M | 10.35M | 0 | 61.51M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -188K | 0 | 0 | 0 | 0 | 2.96M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -119K | -76K | 0 | -13.90M | 0 | -1.45M | 0 | -452.22K | -3.59M |
Cash used in financing activities | -149K | 7.19M | 6.33M | 3.30M | 2.14M | 16.33M | 8.50M | 10.14M | -195.10K | 58.11M |
Net Change In Cash | -10.56M | 19.81M | 477K | 3.71M | -9.38M | 39K | -9.95M | -6.09M | -23.90M | 48.63M |
Cash at end of period | 10.04M | 20.60M | 792K | 4.23M | 511K | 9.54M | 9.50M | 19.45M | 25.55M | 49.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |